HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

50.400

+4.5609.95%

Volume:3.75M

Turnover:182.94M

Market Cap:28.81B

PE:-1.44

High:50.400

Open:46.100

Low:46.100

Close:45.840

52wk High:80.900

52wk Low:29.980

Shares:571.62M

HK Float Shares:571.62M

Volume Ratio:1.08

T/O Rate:0.66%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-35.098

ROE:--

ROA:-11.83%

PB:8.14

PE(LYR):-1.44

PS:65.39

Loading ...

Overview Company News Filings

Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026

THOMSON REUTERS

Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln

THOMSON REUTERS

Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy

BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib

Insilico Medicine Cayman Topco - Receives Center for Drug Evaluation of Nmpa's Ind Approval for Inhaled Rentosertib

THOMSON REUTERS

Insilico Medicine says China CDE approves IND for Rentosertib inhalation solution

INSILICO shifts to fully electronic delivery of corporate communications under HKEX Rule 2.07A

Bulletin Express

英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善

Bulletin Express

InSilico Implements Electronic-Only Distribution of Corporate Communications to Shareholders

Bulletin Express

INSILICO Sets 2 June 2026 Virtual AGM; Eyes 10% Buy-Back Mandate and 20% Issuance Capacity

Bulletin Express

INSILICO to Seek Shareholders’ Nod for 10 % Buyback, 20 % Issuance Mandates and Board Re-election at 2 June Virtual AGM

Bulletin Express

InSilico Medicine Schedules 2 June 2026 Virtual AGM; Director Re-elections, 10% Buyback and 20% Issuance Mandates Proposed

Bulletin Express

Insilico Medicine Cayman Topco announces annual general meeting

Stock Track | Insilico Medicine Plummets 5.16% Intraday as Profit-Taking Persists Amid Strong Sector Performance

Stock Track | Insilico Medicine Plummets 5.65% Intraday as Profit-Taking Follows AI Drug Discovery Rally

Insilico Medicine Nominates AI-Developed Brain Cancer Drug Candidate

MT Newswires Live

BRIEF-Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical Candidate

Insilico's UAE Team Selects First AI-Designed Preclinical Candidate for Regional Drug Development

Insilico Announces 30th AI-Driven Preclinical Candidate ISM0387 Targeting Glioblastoma

Bulletin Express

Insilico Medicine nominates PRMT5 inhibitor ISM0387 as preclinical candidate for glioblastoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/03696/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":50.4,"timestamp":1779437302006,"preClose":45.84,"halted":0,"volume":3754356,"delay":0,"changeRate":0.0994764397905758,"floatShares":571622000,"shares":571622000,"eps":-35.097615242392905,"marketStatus":"Closed The Birthday of the Buddha","change":4.56,"latestTime":"05-22 16:08:22","open":46.1,"high":50.4,"low":46.1,"amount":182936454,"amplitude":0.093805,"askPrice":50.4,"askSize":9000,"bidPrice":50.3,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-37.52624486854063,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779759000000},"marketStatusCode":7,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":45.84,"openAndCloseTimeList":[[1779413400000,1779422400000],[1779426000000,1779436800000]],"volumeRatio":1.0796382283584778,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":571622000,"roa":"-11.83%","roe":"--","lyrEps":-35.097615,"volumeRatio":1.0796382283584778,"shares":571622000,"dividePrice":0,"high":50.4,"amplitude":0.093805,"preClose":45.84,"low":46.1,"week52Low":29.98,"pbRate":"8.14","psRate":"65.39","week52High":80.9,"institutionHeld":0,"latestPrice":50.4,"eps":-35.097615242392905,"divideRate":0,"volume":3754356,"delay":0,"ttmEps":-37.52624486854063,"open":46.1,"prevYearClose":37.14,"prevWeekClose":50.4,"prevMonthClose":63.05,"prevQuarterClose":56,"fiveDayClose":52.95,"twentyDayClose":71.55,"sixtyDayClose":68.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775577600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-05-22","current":-1.343071,"percent":0.979167,"low":-126.474328,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"high":-9.505718,"avg":-64.419587,"sd":41.434215,"marketCap":28849060800},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800}],"updateTime":1779693694303},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631602575","title":"Insilico Medicine Cayman Topco - Co and Unit Subscribes for Wealth Management Products on April 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631602575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631602575?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C20H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631575981","title":"Insilico Medicine Cayman Topco - Subscribes to Cmb International USD Money Market Fund for USD50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631575981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631575981?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:01","pubTimestamp":1777507308,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41C20H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146903525","title":"Stock Track | Insilico Medicine Soars 5.14% Intraday on China IND Approval for Rentosertib IPF Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1146903525","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146903525?lang=en_us&edition=fundamental","pubTime":"2026-04-29 14:27","pubTimestamp":1777444041,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock surged 5.14% during intraday trading on Wednesday, following positive regulatory news regarding its drug development pipeline.The significant price movement comes after the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631239556","title":"BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib","url":"https://stock-news.laohu8.com/highlight/detail?id=2631239556","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631239556?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:36","pubTimestamp":1777426564,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled RentosertibApril 29  - Insilico Medicine Cayman TopCo 3696.HK:RECEIVES CENTER FOR DRUG EVALUATION OF NMPA'S IND APPROVAL FOR INHALED RENTOSERTIBFurther company coverage: 3696.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631558559","title":"Insilico Medicine Cayman Topco - Receives Center for Drug Evaluation of Nmpa's Ind Approval for Inhaled Rentosertib","url":"https://stock-news.laohu8.com/highlight/detail?id=2631558559","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631558559?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:02","pubTimestamp":1777420925,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631855836","title":"Insilico Medicine says China CDE approves IND for Rentosertib inhalation solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2631855836","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631855836?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:01","pubTimestamp":1777420909,"startTime":"0","endTime":"0","summary":"Insilico Medicine received China IND clearance from NMPA CDE for Rentosertib  inhalation solution in adult idiopathic pulmonary fibrosis.Authorization enables a Phase I study assessing safety, tolerability, and pharmacokinetics, with about 80 subjects planned.Rentosertib previously received US FDA orphan drug designation for idiopathic pulmonary fibrosis in February 2023.China CDE added Rentosertib to its breakthrough therapy designation list in May 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1FbVN5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177716963","title":"INSILICO shifts to fully electronic delivery of corporate communications under HKEX Rule 2.07A","url":"https://stock-news.laohu8.com/highlight/detail?id=1177716963","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177716963?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:43","pubTimestamp":1777380200,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) announced that, effective 28 April 2026, all future corporate communications will be provided exclusively in electronic form on the company’s website...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193112249","title":"英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1193112249","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193112249?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:28","pubTimestamp":1777379299,"startTime":"0","endTime":"0","summary":"英妙智能（InSilico Medicine Cayman TopCo，港交所代码：03696）于2025年12月30日成功在香港联交所主板上市，并引入包括礼来（Eli Lilly and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英妙智能2025年报：营收下降与亏损扩大，AI新药研发平台获多方关注，资本结构显著改善","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142051984","title":"InSilico Implements Electronic-Only Distribution of Corporate Communications to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1142051984","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142051984?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:26","pubTimestamp":1777379196,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (英矽智能) has outlined new procedures for delivering corporate communications, moving predominantly to electronic channels in line with Hong Kong Stock Exchange Listing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192868643","title":"INSILICO Sets 2 June 2026 Virtual AGM; Eyes 10% Buy-Back Mandate and 20% Issuance Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=1192868643","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192868643?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:26","pubTimestamp":1777379179,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (abbreviated as INSILICO) will convene its 2026 annual general meeting (AGM) electronically on 2 June 2026 at 9:00 a.m. via the company’s eVoting Portal. Key agenda...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166909294","title":"INSILICO to Seek Shareholders’ Nod for 10 % Buyback, 20 % Issuance Mandates and Board Re-election at 2 June Virtual AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1166909294","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166909294?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:25","pubTimestamp":1777379150,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) has dispatched a circular convening its 2026 annual general meeting (AGM) for 9:00 a.m. on 2 June 2026. The meeting will be conducted exclusively online via...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197863051","title":"InSilico Medicine Schedules 2 June 2026 Virtual AGM; Director Re-elections, 10% Buyback and 20% Issuance Mandates Proposed","url":"https://stock-news.laohu8.com/highlight/detail?id=1197863051","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197863051?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:23","pubTimestamp":1777379007,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO, stock code 03696) will hold its Annual General Meeting electronically through the eVoting Portal on 2 June 2026 at 9:00 a.m. Hong Kong time. Shareholders may...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301060","title":"Insilico Medicine Cayman Topco announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301060","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301060?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:18","pubTimestamp":1777378726,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman Topco will hold its annual general meeting via electronic meeting through eVoting Portal on June 2, 2026.Shareholders will vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Resolutions include re-election of directors, including executive directors Aleksandrs Zavoronkov and Feng Ren.Meeting will also consider re-appointment of Deloitte Touche Tohmatsu as auditor.Additional proposals cover share buyback mandate of up to 10% of issued shares, share issuance mandate of up to 20%, including extension tied to any repurchases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLbrnTjc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177218316","title":"Stock Track | Insilico Medicine Plummets 5.16% Intraday as Profit-Taking Persists Amid Strong Sector Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1177218316","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177218316?lang=en_us&edition=fundamental","pubTime":"2026-04-28 11:42","pubTimestamp":1777347767,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock plummeted 5.16% during Tuesday's intraday session, extending a recent decline.The slide is attributed to continued profit-taking following a significant rally driven by...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175762239","title":"Stock Track | Insilico Medicine Plummets 5.65% Intraday as Profit-Taking Follows AI Drug Discovery Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1175762239","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175762239?lang=en_us&edition=fundamental","pubTime":"2026-04-27 10:57","pubTimestamp":1777258634,"startTime":"0","endTime":"0","summary":"Insilico Medicine's stock experienced a significant intraday decline, plummeting 5.65% during Monday's trading session. This movement follows a period of notable gains for the company.The sharp...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629893818","title":"Insilico Medicine Nominates AI-Developed Brain Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629893818","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629893818?lang=en_us&edition=fundamental","pubTime":"2026-04-24 09:54","pubTimestamp":1776995667,"startTime":"0","endTime":"0","summary":"Insilico Medicine  has nominated a new preclinical drug candidate for glioblastoma using its artificial intelligence platform, according to a Friday Hong Kong bourse filing.The candidate, ISM0387, was developed by the company's United Arab Emirates team using its Pharma.AI system and progressed from design to optimization in under 12 months.Insilico said the drug showed improved activity, selectivity, and brain penetration in early studies, with potential as a treatment for brain cancer.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AIPO","CHAT","BK1141","AGIX","ARTY","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629378898","title":"BRIEF-Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629378898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629378898?lang=en_us&edition=fundamental","pubTime":"2026-04-24 09:28","pubTimestamp":1776994089,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical CandidateApril 24 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK:NOMINATES ISM0387 AS PRECLINICAL CANDIDATEFurther company coverage: 3696.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nFWN41619T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198852916","title":"Insilico's UAE Team Selects First AI-Designed Preclinical Candidate for Regional Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1198852916","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198852916?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:14","pubTimestamp":1776989694,"startTime":"0","endTime":"0","summary":"Insilico has officially nominated ISM0387, a novel MTA-cooperative PRMT5 inhibitor, as a preclinical candidate drug. This molecule was discovered locally by the company's UAE team using its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","03696","ARTY","AGIX","AIPO","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183745135","title":"Insilico Announces 30th AI-Driven Preclinical Candidate ISM0387 Targeting Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1183745135","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183745135?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:04","pubTimestamp":1776989071,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (Insilico) disclosed that its UAE research team has advanced ISM0387, an MTA-cooperative PRMT5 inhibitor, to pre-clinical candidate status. The molecule was generated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629623318","title":"Insilico Medicine nominates PRMT5 inhibitor ISM0387 as preclinical candidate for glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2629623318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629623318?lang=en_us&edition=fundamental","pubTime":"2026-04-24 08:00","pubTimestamp":1776988855,"startTime":"0","endTime":"0","summary":"Insilico Medicine nominated ISM0387, an MTA-cooperative PRMT5 inhibitor, as a preclinical candidate discovered by its UAE team using Pharma.AI.Program completed early discovery workflow in UAE in less than 12 months, including hit generation within 30 days.Lead optimization finished within 6 months, signaling faster cycle times for AI-driven R&D execution.ISM0387 showed improved in vitro activity and selectivity, with enhanced brain penetration.Candidate is positioned as a potential glioblastoma treatment; nomination marked Insilico Medicine’s 30th AI-supported preclinical candidate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLbsYB9r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":191,"code":"91000000","status":"200"}]}}